Trial Profile
Efficacy and safety of Resiniferatoxin in patients suffering from premature ejaculation
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2015
Price :
$35
*
At a glance
- Drugs Resiniferatoxin (Primary)
- Indications Premature ejaculation
- Focus Therapeutic Use
- 17 Sep 2015 New trial record